Diversity and HTN: Approaches to optimal BP control in AfricanAmericans

Similar documents
New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets

Using the New Hypertension Guidelines

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

Hypertension Management Controversies in the Elderly Patient

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

Jared Moore, MD, FACP

JNC 8 -Controversies. Sagren Naidoo Nephrologist CMJAH

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

ADVANCES IN MANAGEMENT OF HYPERTENSION

Management of High Blood Pressure in Adults

Hypertension JNC 8 (2014)

Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic

What is hypertension?

major public health burden

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

Hypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program

ALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic

Preventing and Treating High Blood Pressure

Update in Hypertension

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

Randomized Design of ALLHAT BP Trial

Modern Management of Hypertension

Pharmacy Costs: Can I Make a Difference?

Objectives. Describe results and implications of recent landmark hypertension trials

Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None

Egyptian Hypertension Guidelines

Managing Hypertension in 2016

Hypertension Update Clinical Controversies Regarding Age and Race

RESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University

Renal Disease through the Ages: From Childbearing years to Old Age. Dr Elizabeth Jarvis, Renal Physician, General Physician, Obstetric Physician.

Update on Current Trends in Hypertension Management

Blood Pressure Treatment in 2018

Hypertension Management: A Moving Target

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH)

ADVANCES IN MANAGEMENT OF HYPERTENSION

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Update in Cardiology Pharmacologic Management of Cardiovascular Risk. Christopher C. Roe, MSN, ACNP

Modern Management of Hypertension: Where Do We Draw the Line?

Hypertension Guidelines: Are We Pressured to Change? Oregon Cardiovascular Symposium Portland, Oregon June 6, Financial Disclosures

Antihypertensive Trial Design ALLHAT

Hypertension in the Elderly. John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents

DEPARTMENT OF GENERAL MEDICINE WELCOMES

Hypertension. Most important public health problem in developed countries

HYPERTENSION: ARE WE GOING TOO LOW?

Blood Pressure LIMBO How Low To Go?

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

From the desk of the: THE VIRTUAL NEPHROLOGIST

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

Hypertension (JNC-8)

Hypertension in the very old. Objectives: Clinical Perspective

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

How Low Do We Go? Update on Hypertension

Prevention of Heart Failure: What s New with Hypertension

SAURIN GANDHI, AZCOM Evidence-Based Guideline for the Management of High Blood Pressure in Adults (JNC 8)

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

Hypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS

Treating Hypertension in Individuals with Diabetes

Hypertension. Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Hypertension Update Background

Hypertension and the 2017 Guidelines Meeting the Targets in Small Groups. Lisa Ivy APRN

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

Hypertension Management in Minorities: Closing the gap

Combination Therapy for Hypertension

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories

Clinical Recommendations: Patients with Periodontitis

Established Risk Factors for Coronary Heart Disease (CHD)

Cardiac Pathophysiology

Understanding the importance of blood pressure control An overview of new guidelines: How do they impact daily current management?

Hypertension Update. Aaron J. Friedberg, MD

Hypertension and the SPRINT Trial: Is Lower Better

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair

2014 HYPERTENSION GUIDELINES

Managing High Blood Pressure Naturally. Michael A. Smith, MD Life Extension s Healthy Talk Series

Slide notes: This presentation highlights the issues involved in preventing hypertension. Slide notes are included for the majority of slides,

What s In the New Hypertension Guidelines?

The prevalence of hypertension in a representative

Diabetes and Hypertension

C h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario

Layered Approaches to Studying Drug Responses

Difficult to Treat Hypertension

Hypertension Update 2009

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

Hypertension 2015: Recent Evidence that Will Change Your Practice

Dysglycaemia and Hypertension. Dr E M Manuthu Physician Kitale

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

We are delighted to have Dr. Roetzheim with us today to discuss Managing Hypertension in Older Adult Patients.

CONCORD INTERNAL MEDICINE HYPERTENSION PROTOCOL

The JNC 8 Guidelines: A Clinical Review

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)

Transcription:

Diversity and HTN: Approaches to optimal BP control in AfricanAmericans Quinn Capers, IV, MD, FACC, FSCAI Assistant Professor of Medicine Associate Dean for Admissions

Do Racial Differences Really Exist in HTN? Hypertension is very complex Hypertension is polygenic phenotype (many different gene products contribute to elevated BP from gene products that influence electrolyte metabolism, CNS reflexes, VSMC growth, etc.) Very difficult to separate the impact of race on BP separate from the impact of culture, geography, and socioeconomic status Despite these realities, some differences do exist and are measurable

Racial Differences in Hypertension: Renal/Fluid Balance Whites excrete a water load more rapidly than blacks Alan B. Weder, MD, * et al. Hypertension 2009 April 53 (4):715-718 Ethnic Differences in Renal Responses to Furosemide Tae-Yon Chun, et al. Hypertension. 2008; 52: 241-248 Determinants of salt sensitivity in black and white normotensive and hypertensive women. Wright JT Jr, et al. Hypertension. 2003 Dec;42(6):1087-92.

Racial Differences in Hypertension: Vascular Mechanisms Racial differences in aortic stiffness in normotensive and hypertensive adults.ferreira et al. J Hypertens. 1999 May;17(5):631-7. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Kalinowski L, et al. Circulation. 2004 Jun 1;109(21):2511-7. Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation. Cardillo C, et al. Hypertension. 1998;31:1235-1239

Racial Differences in Hypertension Available data seem to suggest that, compared to Whites, African Americans with hypertension on average: Are more salt sensitive Have higher large vessel tone Are less sensitive to the vasodilating effects of N.O.

6 Racial Differences in Hypertensive-End Organ Damage

Target Organ Damage in Hypertension: Left Ventricular Hypertrophy LVH is an independent risk factor for CHF, MI, stroke, and death in hypertensive patients Compared to Whites with similar BP levels, African Americans have higher incidence of LVH 7

Target Organ Damage in Hypertension: Congestive Heart Failure Racial differences in incident heart failure during antihypertensive therapy. Okin PM, et al. Circ Cardiovasc Qual Outcomes. 2011 Mar 1;4(2):157-64. 497 Black, 8199 Non Black pts with HTN and no CHF Treated with Losartan and Atenolol Odds Ratio for Incident ( On Treatment ) Heart Failure Blacks vs Non-Blacks: 2.30

Target Organ Damage in Hypertension: Kidney Failure Rate of ESRD from 2-5 times higher in Black vs White Hypertensives Among ESRD pts under age 50, death rate of Blacks>Whites

Target Organ Damage in Hypertension: Stroke Compared to Whites with the same BP, Blacks are significantly more likely to suffer a stroke Post stroke mortality in Blacks is significantly worse than in Whites 10

Racial Differences in Hypertensive-End Organ Damage For the same level of BP, Compared to Whites, Blacks are More likely to suffer from: LVH CHF Stroke ESRD 11

12 Is the Hypertension Suffered by Blacks a more Malignant variety?

Changes in BP Classification 13 Hypertension 2003;289:2560-2572.

Pre-Hypertension 130/80-139/89 (non-diabetics) New concept (7 th JNC on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, JAMA 2003) Individuals with pre-hypertension twice as likely to develop HTN as those with lower BPs

Pre-Hypertension Identified as a group to be targeted with aggressive lifestyle changes, (? Drug therapy?) Progression is accelerated from prehypertension to hypertension in blacks. Hypertension. 2011 Oct;58(4):579-87. Epub 2011 Sep 12.

Epidemiology Benefits of lowering BP: 50% reduction in risk of developing CHF 35-40% reduction in risk of stroke 20-25% reduction in risk of MI

Hypertension Management in African Americans Significant number of patients still without adequate BP control 1991-1994: 27% of patients with HTN were controlled 1999-2000: 34% of patients with HTN were controlled The numbers for African Americans are worse

Impact of a 5 mmhg Reduction Overall Reduction Stroke 14% Coronary Heart Disease 9% All Cause Mortality 7% Hypertension 2003;289:2560-2572.

Weight reduction DASH eating plan Na restriction Physical activity Reduce EtOH intake Lifestyle intervention Maintain normal body weight Consume a diet rich in fruits, vegetables, and low-fat dairy products with a reduced content of saturated and total fat. Reduce dietary sodium intake to no more than 100 mmol per day (2.4 g sodium or 6 g sodium chloride). Engage in regular aerobic physical activity such as brisk walking (at least 30 minutes per day, most days of the week). Limit consumption to no more than 2 drinks (eg, 24 oz beer, 10 oz wine, or 3 oz 80- proof whiskey) per day in most men and to no more than 1 drink per day in women and lighter-weight persons. BP lowering 5 20 mm Hg/10 kg 8 14 mm Hg 2 8 mm Hg 4 9 mm Hg 2 4 mm Hg 19 Modified from Chobanian, et al, JNC 7 Report on Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003

Racial Differences in Responses to Different Drugs Have Been Documented. But Are They Clinically Important? Compared to Whites, Black hypertensives tend to be: Less responsive to beta blockers More responsive to CCBs Very sensitive to diuretics Less responsive to ACE inhibitors

21 But, remember, although racial differences in response to different antihypertensive classes have been reported, there is always... The Great Equalizer

Optimizing Drug Therapy for Hypertension in Blacks Am J Med. 1996 Sep 30;101(3A):22S-32S.The impact of ethnicity on response to antihypertensive therapy.jamerson K, DeQuattro V. Thus, there is little justification to use racial profiling as a criterion for the avoidance of selected drug classes because of presumed lack of efficacy. This could result in depriving African Americans of the important cardiovascular and renal therapeutic benefits of ACE inh/arbs and beta blockers

Optimizing Drug Therapy for Hypertension in Blacks Items for consideration in African American hypertensive patients: Tend to be salt sensitive (diuretics) Tend to have increased vascular tone (calcium channel blockers) Are at particularly high risk for suffering LVH, CHF, renal failure,and strokes (think ACE inh/arbs, diuretics)

Hypertension: Principles of Treatment Pharmacologic treatments Step 1: determine if HTN is accompanied by complications (end organ damage) or other cardiovascular risk factors (DM, CAD, etc.). If so, controlling the BP is urgent

Antihypertensive and Lipid-Lowering to Prevent Heart Attack Trail (ALLHAT) Randomized, double blind, multi-center, study Conducted between 1994-2002, average follow-up 4.9 years N=33,357 Evaluate weather CCB, ACEI or Doxazosin would decrease fatal coronary heart disease, or non-fatal MI when compared to a diuretic ALLHAT. JAMA. 2002 288(23):2981-97

ALLHAT: Endpoints Primary Endpoint Fatal coronary heart disease or non-fatal MI Secondary Endpoints: All cause mortality Fatal and non-fatal stroke Combined coronary heart disease Combined cardiovascular disease Goal Blood Pressure: <140/90 ALLHAT. JAMA. 2002 288(23):2981-97

ALLHAT: Inclusion Inclusion: > 55 years old Stage 1 or 2 HTN With one risk factor: Prior MI or stroke > 6 mo in past LVH Type 2 Diabetes Smoker HDL <35 Atherosclerotic cardiovascular disease ALLHAT. JAMA. 2002 288(23):2981-97

ALLHAT: Patients Average age = 67 Black 32% Women 47% Baseline BP: 146/84 Receiving antihypertensive treatment 90% Prior MI or Stroke: 23% Type 2 Diabetes: 36% ALLHAT. JAMA. 2002 288(23):2981-97

ALLHAT: Cumulative Event Rates for Fatal Coronary Heart Disease or Nonfatal MI ALLHAT. JAMA. 2002 288(23):2981-97

Optimizing Drug Therapy for Hypertension in Blacks: A Rational Approach Based on ALLHAT and JNC-7 Begin with a thiazide-type diuretic If SBP>160, begin with two agents, one of which should be a thiazide-type diuretic Combination pills are well tolerated and work well in African Americans

Hypertension: Principles of Treatment List and Take Into Account Compelling Indications : CHF, LV systolic dysfunction Include ACE inh/arb and a CHF beta blocker (carvedilol/toprol xl/bisoprolol Renal insufficiency Include ACE inh/arb. Will need a diuretic to control BP Diabetes Include ACE inh/arb

Hypertension: Principles of Treatment CAD, history of MI Include a beta blocker and an ACE inh/arb History of stroke Include ACE inhibitor

Case 1 72 year old African American woman PMHx: CAD, LVEF=>65%, Diabetes x 15 years, mild renal insufficiency (creat 1.6 mg/dl), LVH on EKG BP 168/60 End organ damage (LVH, CAD) and 2 compelling indications for specific antihypertensive drug classes. Her BP will probably not be controlled by a single agent Rx: ACE inh or ARB for DM and renal protection Diuretic will be necessary to control BP and volume Beta blocker for CAD Rx: ACE/HCTZ combination, beta blocker

Case 2 45 year old African American man 1.5 ppd smoker, drinks two six packs of beer/wk, truncal obesity, fundoscopy normal, EKG normal, no diabetes or CHF BP 150/94 No evidence of target organ damage or compelling indications. There is time for non-drug treatments first. Tobacco cessation, reduce EtOH consumption, walk 30 min/day, follow up in 4-6 months

Summary Hypertension is a major risk factor for cardiovascular disease and death African Americans have the highest prevalence of hypertension among all racial ethnic groups in US African Americans seem to suffer disproportionately from complications of hypertension

Summary There are some documented differences in racial responses to antihypertensive drug classes Thiazide diuretics are particularly effective, have been shown to reduce adverse outcomes, and can help override racial unresponsiveness to certain drugs Compelling indications and end organ damage should be taken into account